Henry Schein | HSIC - Sales Revenues


Henry Schein reported $3.46B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Agilent USD 1.88B 43M Jun/2026
Align Technology USD 1.06B 20M Jun/2026
Bruker USD 838.5M 15.1M Jun/2026
Cardinal Health USD 63.7B 2.8B Jun/2026
Charles River Laboratories USD 1000M 4.2M Jun/2026
Cigna USD 71.7B 3.18B Jun/2026
Concord Medical Services Hldg CNY 259.9M 59.28M Dec/2025
Cooper Companies USD 1.07B 15.3M Jun/2026
CVS Health USD 106.1B 5.7B Jun/2026
Danaher USD 6.55B 254M Sep/2026
Dentsply International USD 898M 18M Jun/2026
Encompass Health USD 1.6B 10M Jun/2026
Henry Schein USD 3.46B 90M Jun/2026
Idexx Laboratories USD 1.22B 80M Jun/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
Laboratory Of America USD 3.73B 190M Jun/2026
McKesson USD 105.38B 13.08B Jun/2026
Mettler Toledo International USD 1.03B 82.87M Jun/2026
Owens Minor USD 708.97M 11.71M Dec/2025
Quest Diagnostics USD 3.1B 57M Sep/2026
Revvity USD 729.68M 18.68M Jun/2026
Stryker USD 6.6B 600M Jun/2026
Tenet Healthcare USD 5.63B 260M Jun/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Universal Health Services USD 4.73B 90M Sep/2026
Veradigm USD 142.52M 9.38M Dec/2022
Waters USD 1.64B 370M Jun/2026
Zimmer Biomet Holdings USD 2.18B 90M Jun/2026
Zoetis USD 2.5B 200M Jun/2026